The Global Bioimpedance Analyzers Market size is expected to reach $1.1 billion by 2030, rising at a market growth of 9.2% CAGR during the forecast period. In the year 2022, the market attained a volume of 3,42,604 Units experiencing a growth of 2.0% (2019-2022).
Health clubs and gyms use bioimpedance analyzers to evaluate a member’s baseline body composition and monitor improvement over time. These assessments help trainers and members set realistic fitness goals and tailor exercise and nutrition plans. Therefore, Fitness Clubs & Wellness Centers segment would generate $216.7 million revenue in the market in 2022. The growing number of fitness clubs, sports rehabilitation centers, and weight loss clinics is a significant factor contributing to the expansion of the market. These establishments have a high demand for such analyzers to assess and monitor their clients’ body composition, hydration status, and overall health. These assessments help trainers and members set realistic fitness goals and tailor exercise and nutrition plans. Some of the factors impacting the market are increasing prevalence of lifestyle diseases, rising integration of BIA with wearable devices and presence of alternative body composition assessment methods.
Lifestyle diseases such as obesity and overweight are major health concerns globally, including in North America, Europe, Asia, and beyond. Bioimpedance analyzers measure body fat percentage, a key indicator in obesity management. As obesity continues to rise, there is an increased demand for these devices to help individuals and healthcare professionals monitor and manage weight-related issues. According to WHO, over 1 billion individuals worldwide are obese – 650 million adults, 340 million adolescents, and 39 million children. This number is still increasing. WHO estimates that by 2025, approximately 167 million people – adults and children – will become less healthy because they are overweight or obese. Additionally, integrating bioimpedance analyzers with wearable devices is a significant trend that can potentially boost the market. This integration adds convenience, accessibility, and real-time monitoring capabilities, making bioimpedance measurements more accessible to individuals and healthcare professionals. Wearable devices, such as fitness trackers and smartwatches, are widely adopted by individuals for tracking various health and fitness metrics. Integrating bioimpedance analyzers into these wearables makes it convenient for users to access body composition and hydration data without needing separate devices or clinical appointments. As a result, these devices offer non-invasive and informative assessments, making them valuable tools in managing and preventing lifestyle-related health conditions, due to which the market will expand and as the demand for wearable health and fitness technology continues to grow, this integration is likely to drive the adoption of bioimpedance analyzers and contribute to the expansion of the market.
However, Advances in alternative methods, such as portable DXA devices or improved skinfold measurement techniques, can further challenge the bioimpedance analyzer market by enhancing the competitiveness of these alternatives. Due to their education and training, healthcare providers and researchers may already be familiar with alternative methods. This familiarity can create resistance to adopting new technologies like bioimpedance analyzers. The level of awareness and understanding of bioimpedance technology compared to well-established alternative methods can affect its adoption rate. Therefore, these factors may hinder market growth.
Additionally, The COVID-19 pandemic had moderately affected the market. Like many industries, the medical device sector experienced supply chain disruptions due to the pandemic. This could lead to delays in the manufacturing and distribution bioimpedance analyzers, affecting market availability. Hospitals and healthcare facilities were under immense pressure during the pandemic, leading to budget constraints. This affected their ability to invest in new medical devices, including bioimpedance analyzers. Regulatory agencies temporarily adjusted regulations to expedite the approval and use of medical devices, including bioimpedance analyzers, in response to the pandemic. This impacted market dynamics and product availability.
Modality Outlook
Based on modality, the market is bifurcated into wired and wireless. The wireless segment held the highest revenue share in the market in 2022. Wireless bioimpedance analyzers are medical devices that measure and diagnose the electrical impedance of biological tissues within the body without needing physical connections, such as wires and cables. These analyzers use wireless technology to transmit data from the electrodes to a display or data processing unit. Wireless bioimpedance analyzers send a low-frequency electrical current through the body via the current electrodes and measure the voltage across the tissue using the voltage electrodes. The impedance is then calculated based on these measurements and wirelessly transmitted to a connected device.
Product Outlook
On the basis of product, the market is segmented into multi-frequency, single- frequency, and dual- frequency. The single-frequency segment acquired a substantial revenue share in the market in 2022. Single frequency bioimpedance analyzers are medical devices that use a single frequency of electrical current to measure the electrical impedance of biological tissues within the body. These devices are designed to provide a basic assessment of body composition and hydration levels. Single-frequency analyzers pass a low-level electrical current through the body and measure the impedance, which opposes the flow of electrical current. The composition and properties of various tissues, including fat, muscle, and water, influence the impedance measurement. These analyzers can also provide information about hydration levels within the body. They are used to monitor changes in fluid balance, which can be essential for medical conditions and sports performance.
Application Outlook
On the basis of application, the market is divided into whole-body measurement and segmental-body measurement. In 2022, the segmental-body measurement segment witnessed the largest revenue share in the market. Segmental-body measurement in bioimpedance analyzers involves individually assessing the electrical impedance of specific body segments or compartments. This approach provides more detailed insights into body composition and fluid distribution within different body parts. Segmental measurements are particularly valuable for identifying muscle and fat distribution imbalances and monitoring changes in specific areas of interest. Segmental measurements can help identify muscle imbalances between the upper and lower body or between different limbs. This is valuable for athletes, fitness enthusiasts, and rehabilitation patients who need targeted training or therapy to address specific weaknesses.
Usage Type Outlook
By usage type, the market is segmented into consumer-grade and professional-grade. In 2022, the consumer-grade segment registered a remarkable revenue share in the market. Consumer-grade bioimpedance analyzers are health and wellness devices designed for personal use by individuals interested in monitoring their body composition, hydration levels, and other health-related metrics. These analyzers are typically user-friendly, portable, and accessible to the general public. These analyzers are designed to be user-friendly and require minimal setup and operation. Many consumer models are integrated into bathroom scales or handheld devices, easily incorporating them into daily routines.
End User Outlook
Based on end user, the market is fragmented into hospitals & clinics, fitness clubs & wellness centres, home users, and others. The fitness clubs & wellness centers segment acquired the highest revenue share in the market in 2022. Bioimpedance analyzers are valuable tools in fitness clubs and wellness centers, where they are used to assess and monitor the body composition and hydration levels of individuals seeking to improve their health and fitness. These devices provide valuable data that can guide personalized fitness and nutrition plans. Bioimpedance analyzers measure and track body composition, including fat percentage, lean body mass, and bone density. This information helps individuals understand their physical state and set realistic fitness goals. Fitness clubs and trainers use bioimpedance measurements to conduct baseline assessments of clients’ body composition. These assessments serve as a starting point for personalized fitness programs. Fitness clubs often organize challenges and competitions among their members. Bioimpedance analyzers can track participants’ progress and determine challenge winners.
Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating maximum revenue share. Bioimpedance analyzers are widely used in North America across various sectors, including healthcare, fitness and wellness, research, and sports. These devices play a significant role in assessing body composition, hydration levels, and tissue characteristics. Bioimpedance analyzers have become integral tools for evaluating and managing health and fitness across North America. Their versatility and non-invasive nature make them valuable for clinical and consumer applications, contributing to the region’s improved healthcare and wellness outcomes.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include OMRON Corportion, Tanita Corporation, Inbody Co., Ltd., RJL Systems, SECA GMBH & Co. KG, Maltron International Limited, Selvas Healthcare, Fook Tin Technologies Ltd., Bodystat Ltd. and Charder Electronics Co. Ltd.
Bioimpedance Analyzers Market Report Coverage:
Report Attribute Details
Market size value in 2022 USD 535.8 Million
Market size forecast in 2030 USD 1.1 Billion
Base Year 2022
Historical period 2019 to 2021
Forecast Period 2023 to 2030
Revenue Growth Rate CAGR of 9.2% from 2023 to 2030
Quantitative Data Volume in Units, Revenue in USD Million, and CAGR from 2019 to 2030
Number of Pages 469
Tables 1010
Report coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Market Share Analysis, Companies Strategic Developments, Company Profiling
Segments covered Modality, Product, Application, Usage Type, End User, Region
Country scope US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers ? Increasing prevalence of lifestyle diseases
? Rising integration of BIA with wearable devices
Restraints ? Presence of alternative body composition assessment methods
Scope of the Study
Market Segments covered in the Report:
By Modality (Volume in Units, USD Million, 2019-2030)


    • Wireless
    • Wired


By Product (Volume in Units, USD Million, 2019-2030)


  • • Multi-frequency
    • Single-frequency
    • Others


By Application (Volume in Units, USD Million, 2019-2030)


  • • Segmental Body Measurement
    • Whole Body Measurement


By Usage Type (Volume in Units, USD Million, 2019-2030)


  • • Professional Grade
    • Consumer Grade


By End User (Volume in Units, USD Million, 2019-2030)


  • • Fitness Clubs & Wellness Centers
    • Hospitals & Clinics
    • Home Users
    • Others


By Geography (Volume in Units, USD Million, 2019-2030)


  • • North America


o US
o Canada
o Mexico
o Rest of North America


  • • Europe


o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe


  • • Asia Pacific


o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific


  • • LAMEA


o Brazil
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA
Companies Profiled


  • • OMRON Corportion
    • Tanita Corporation
    • Inbody Co., Ltd.
    • RJL Systems
    • SECA GMBH & Co. KG
    • Maltron International Limited
    • Selvas Healthcare
    • Fook Tin Technologies Ltd.
    • Bodystat Ltd.
    • Charder Electronics Co. Ltd.


Unique Offerings from KBV Research


  • • Exhaustive coverage
    • Highest number of market tables and figures
    • Subscription based model available
    • Guaranteed best price
    • Assured post sales research support with 10% customization free